Buscar resultados de ensayos clínicos
Chromosome Deletion - 16 Studies Found
Estado | Estudiar |
Active, not recruiting |
Nombre del estudio: Aneuploidies in Embryos and Spermatozoa From Patients With Y-chromosome Microdeletions Condición: Male Sterility Due to Y-chromosome Deletions Fecha: 2015-08-11 |
Terminated |
Nombre del estudio: A Dose Range Finding Study of Lenalidomide in Non-5q Chromosome Deletion in Low and Intermediate Risk Myelodysplastic Syndrome (MDS) Patients Condición:
Intervenciones: Drug: Lenalidomide Dose Level Lenalidomide Schedule |
Completed |
Nombre del estudio: Mitochondrial Dysfunction in Phelan-McDermid Syndrome: Explaining Clinical Variation and Providing a Path Towards Treatment Condición: Phelan-McDermid Syndrome Fecha: 2013-11-25 |
Recruiting |
Nombre del estudio: Treatment Strategies for Children With Smith-Magenis Syndrome Condición:
Intervenciones: |
Recruiting |
Nombre del estudio: Expanded Noninvasive Genomic Medical Assessment: The Enigma Study Condición:
Intervenciones: Other: Blood sampling for Laboratory Developed Test (LDT) analysis Each enrolled subject, either in the |
Recruiting |
Nombre del estudio: Piloting Treatment With Intranasal Oxytocin in Phelan-McDermid Syndrome Condición: Phelan-McDermid Syndrome Fecha: 2016-03-07 Intervenciones:
|
Completed |
Nombre del estudio: Clinical Trial in 22q13 Deletion Syndrome(Phelan-McDermid Syndrome) Condición:
Fecha: 2012-02-01 Intervenciones:
|
Completed |
Nombre del estudio: Study of the Pathophysiological Mechanisms Involved in Bleeding Events Condición: Oculocerebrorenal Syndrome Fecha: 2011-03-11 Intervenciones: Other: Blood sample Blood sample |
Enrolling by invitation |
Nombre del estudio: Sulfamethoxazole for the Treatment of Primary PREPL Deficiency Condición:
Fecha: 2015-10-07 Intervenciones: Drug: Sulfamethoxazole 60 mg sulfamethoxazole per kg bodyweight (maximal of 3g) divided in 2 doses per d |
Active, not recruiting |
Nombre del estudio: RA-2 13-cis Retinoic Acid (Isotretinoin) Condición:
|